Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Grows By 44.1%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 377,600 shares, an increase of 44.1% from the December 15th total of 262,000 shares. Based on an average daily volume of 1,060,000 shares, the short-interest ratio is presently 0.4 days. Currently, 11.0% of the shares of the stock are sold short.

China SXT Pharmaceuticals Stock Performance

SXTC stock traded up $0.02 during trading on Thursday, hitting $0.41. The company had a trading volume of 85,490 shares, compared to its average volume of 813,949. The firm has a 50-day moving average price of $0.42 and a 200-day moving average price of $0.68. China SXT Pharmaceuticals has a 12 month low of $0.30 and a 12 month high of $3.37.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.